Edge Systems, LLC designs, develops, manufactures, markets, and sells aesthetic technologies and products. It offers hydradermabrasion system that enhances the skin to cleanse, exfoliate, extract, and hydrate simultaneously; Hydraglucan Intense Hydration Booster, a customization for the HydraFacial treatment exfoliates the skin by improving cell renewal and delivers ingredients, including hyaluronic acid, glucan, and betaine to hydrate the skin and provide anti-aging benefits; HydraFacial Daily Essentials, which provides detoxification, rejuvenation, and protection of skin; crystal microdermabrasion systems; and light emitting diode systems. The company also provides HydraFacial CONNECT platform, a three-level industry certification program that will advance aesthetic professionals' skills and give them recognition, respect, and rewards; and system surgical smoke evacuators that vacuums the plume created by laser and electrocautery treatments, such as hair removal, tattoo removal, erbium, and veterinary procedures. Its system surgical smoke evacuators are used by hospitals, plastic surgeons, cosmetic surgeons, OB/GYN, veterinarians, and others. In addition, it offers marketing support services. Its products are distributed worldwide through its sales network. The company was founded in 1997 and is based in Signal Hill, California with a location in Long Beach, California.
IPO Year: 2020
Exchange: NASDAQ
Website: hydrafacial.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 11/15/2023 | $11.00 → $1.50 | Buy → Hold | Jefferies |
| 11/14/2023 | $10.00 → $2.50 | Buy → Hold | Canaccord Genuity |
| 11/14/2023 | Neutral → Underweight | JP Morgan | |
| 11/14/2023 | $12.00 → $2.00 | Overweight → Underweight | Piper Sandler |
| 11/14/2023 | $9.00 → $2.50 | Outperform → Market Perform | TD Cowen |
| 11/14/2023 | Buy → Hold | The Benchmark Company | |
| 11/14/2023 | Mkt Perform → Underperform | Raymond James | |
| 11/14/2023 | Outperform → Mkt Perform | William Blair | |
| 8/25/2023 | $10.00 | Buy | Canaccord Genuity |
| 6/21/2023 | $17.00 → $10.00 | Buy → Hold | Stifel |
4 - Beauty Health Co (0001818093) (Issuer)
Delivers third quarter net sales of $78.8 million; Delivers improved profitability as strategic initiatives start to take hold Successfully launches Hydralock HA Booster The Beauty Health Company (NASDAQ:SKIN) ("BeautyHealth"), home to flagship brand Hydrafacial, today announced financial results for the third quarter ended September 30, 2024 ("Q3 2024"). "We delivered revenue above the midpoint of our guidance, with growth in consumables sales driven by sustained demand for Hydrafacial treatments and the successful launch of the Hydralock HA Booster," said BeautyHealth Chief Executive Officer Marla Beck. "Our ability to expand gross margins and achieve adjusted EBITDA profitability
The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial™, today announced it will report third quarter 2024 financial results after market close on Tuesday, November 12, 2024. The Company will host an investor conference call at 4:30 p.m. Eastern Time, following a press release detailing the results. A live webcast of the call can be accessed on the Company's investor relations website at https://investors.beautyhealth.com, along with supporting materials. A recording of the call will become available on the site approximately three hours after its conclusion. Disclosure Information The Beauty Health Company announces material information to the public through a varie
Delivers second quarter net sales of $90.6 million; Year-over-year operating expense improvement of nearly $18 million or 22%; Revises full year financial guidance The Beauty Health Company (NASDAQ:SKIN) ("BeautyHealth"), home to flagship brand Hydrafacial, today announced financial results for the second quarter ended June 30, 2024 ("Q2 2024"). For the quarter, net sales of $90.6 million decreased (22.9)% relative to the same period in 2023. Second quarter results reflect lower equipment sales partially offset by steady growth in consumables net sales. "Our second quarter results reflect continued demand for Hydrafacial treatments with growth in consumables sales, offset by a slowe
The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial™, today announced it will report second quarter 2024 financial results after market close on Thursday, August 8, 2024. The Company will host an investor conference call at 4:30 p.m. Eastern Time, following a press release detailing the results. A live webcast of the call can be accessed on the Company's investor relations website at https://investors.beautyhealth.com, along with supporting materials. A recording of the call will become available on the site approximately three hours after its conclusion. Disclosure Information The Beauty Health Company announces material information to the public through a var
Delivers first quarter net sales of $81.4 million; year-over-year operating expense improvement of $6.1 million Repurchases $192.3 million of convertible notes through May 8th The Beauty Health Company (NASDAQ:SKIN) ("BeautyHealth"), home to flagship brand Hydrafacial, today announced financial results for the first quarter ended March 31, 2024. First quarter net sales of $81.4 million decreased (5.7)% relative to the same period in 2023. First quarter results reflect lower equipment sales substantially offset by steady growth in consumables net sales. "Our first quarter results demonstrate the progress we are making on our near-term strategic priorities, including sales excellence, o
The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial™, today announced it will report first quarter 2024 financial results after market close on Thursday, May 9, 2024. The Company will host an investor conference call at 4:30 p.m. Eastern Time, following a press release detailing the results. A live webcast of the call can be accessed on the Company's investor relations website at https://investors.beautyhealth.com, along with supporting materials. A recording of the call will become available on the site approximately three hours after its conclusion. Disclosure Information The Beauty Health Company announces material information to the public through a variety o
Delivers net sales of $398 million for the full year and $96.8 million for the fourth quarter driven by growth across international markets The Beauty Health Company (NASDAQ:SKIN) ("BeautyHealth"), home to flagship brand Hydrafacial, today announced financial results for the full year and fourth quarter ended December 31, 2023. Full year net sales of $398.0 million increased 8.8% relative to 2022, with fourth quarter net sales of $96.8 million decreasing (1.3)% year-over-year. Fourth quarter results reflect lower equipment sales in the Americas, substantially offset by steady growth in Americas consumables net sales and strong device placement in Asia-Pacific. "To close 2023, we deliver
The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial™, today announced it will now report fourth quarter and full year 2023 financial results on Tuesday, March 12, 2024, rather than on February 29, 2024, as initially announced. The Company will share results during an investor conference call and webcast at 4:30 p.m. ET on Tuesday, March 12, following a press release detailing the results. A live webcast of the call can be accessed on the Company's investor relations website at https://investors.beautyhealth.com, along with supporting materials. A recording of the call will become available on the site approximately three hours after its conclusion. The Company ha
The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial™, today announced it will report fourth quarter and full year 2023 financial results after market close on Thursday, February 29, 2024. The Company will host an investor conference call at 4:30 p.m. Eastern Time, following a press release detailing the results. A live webcast of the call can be accessed on the Company's investor relations website at https://investors.beautyhealth.com, along with supporting materials. A recording of the call will become available on the site approximately three hours after its conclusion. Disclosure Information The Beauty Health Company announces material information to the pub
Revises financial guidance on lower-than-expected U.S. revenue and incurs restructuring charges for device upgrades Delivers net sales of $97.4 million driven by double digit growth in APAC and EMEA The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial, today announced financial results for the third quarter ended September 30, 2023. For the quarter, net sales of $97.4 million increased +10% year-over-year, on the strength of performance in Asia-Pacific, including China, and EMEA. The quarter was overshadowed by lower-than-expected U.S. revenue and $63.1 million in restructuring charges related to device upgrades of early generation Syndeo devices. As a result, t
Jefferies downgraded The Beauty Health Company from Buy to Hold and set a new price target of $1.50 from $11.00 previously
JP Morgan downgraded The Beauty Health Company from Neutral to Underweight
Canaccord Genuity downgraded The Beauty Health Company from Buy to Hold and set a new price target of $2.50 from $10.00 previously
Piper Sandler downgraded The Beauty Health Company from Overweight to Underweight and set a new price target of $2.00 from $12.00 previously
TD Cowen downgraded The Beauty Health Company from Outperform to Market Perform and set a new price target of $2.50 from $9.00 previously
The Benchmark Company downgraded The Beauty Health Company from Buy to Hold
Raymond James downgraded The Beauty Health Company from Mkt Perform to Underperform
William Blair downgraded The Beauty Health Company from Outperform to Mkt Perform
Canaccord Genuity resumed coverage of The Beauty Health Company with a rating of Buy and set a new price target of $10.00
Stifel downgraded The Beauty Health Company from Buy to Hold and set a new price target of $10.00 from $17.00 previously
4 - Beauty Health Co (0001818093) (Issuer)
4 - Beauty Health Co (0001818093) (Issuer)
4 - Beauty Health Co (0001818093) (Issuer)
4 - Beauty Health Co (0001818093) (Issuer)
4 - Beauty Health Co (0001818093) (Issuer)
4 - Beauty Health Co (0001818093) (Issuer)
4 - Beauty Health Co (0001818093) (Issuer)
4 - Beauty Health Co (0001818093) (Issuer)
4 - Beauty Health Co (0001818093) (Issuer)
4 - Beauty Health Co (0001818093) (Issuer)
Delivers third quarter net sales of $78.8 million; Delivers improved profitability as strategic initiatives start to take hold Successfully launches Hydralock HA Booster The Beauty Health Company (NASDAQ:SKIN) ("BeautyHealth"), home to flagship brand Hydrafacial, today announced financial results for the third quarter ended September 30, 2024 ("Q3 2024"). "We delivered revenue above the midpoint of our guidance, with growth in consumables sales driven by sustained demand for Hydrafacial treatments and the successful launch of the Hydralock HA Booster," said BeautyHealth Chief Executive Officer Marla Beck. "Our ability to expand gross margins and achieve adjusted EBITDA profitability
The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial™, today announced it will report third quarter 2024 financial results after market close on Tuesday, November 12, 2024. The Company will host an investor conference call at 4:30 p.m. Eastern Time, following a press release detailing the results. A live webcast of the call can be accessed on the Company's investor relations website at https://investors.beautyhealth.com, along with supporting materials. A recording of the call will become available on the site approximately three hours after its conclusion. Disclosure Information The Beauty Health Company announces material information to the public through a varie
The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial™, announced today that a video poster abstract presentation on the efficacy and safety of Hydrafacial treatments combined with non-ablative fractional laser and intense pulsed light (IPL) full-face treatments will be featured at the American Society for Dermatologic Surgery (ASDS) meeting in Orlando, Florida from October 17-20, 2024. "This presentation on the clinical efficacy and safety of Hydrafacial treatments combined with non-ablative fractional laser or IPL full-face treatments represents a significant milestone for Hydrafacial," said Marla Beck, Chief Executive Officer of BeautyHealth. "Although Hydrafacial
The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial, today announced the appointment of two accomplished industry executives to its commercial leadership team. Ron Menezes will join Beauty Health as Chief Revenue Officer and Carrie Caulkins will join the Company as Chief Marketing Officer, effective October 15, 2024, with both reporting to the Company's Chief Executive Officer, Marla Beck. Mr. Menezes assumes his new role from Dan ("Doc") Watson, who is leaving Beauty Health and will assist with the transition through year-end. Ms. Caulkins fills an open position. Marla Beck commented on the appointments, "We are thrilled to welcome Ron and Carrie to the executive t
Scholarships in Partnership with Beauty Changes Lives Will Help Empower Individuals Who Aspire to Build a Career and Business in the Growing Field of Esthetics The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial™, today announced the introduction of the Hydrafacial Glow Getter Scholarship program, a program that supports aspiring and licensed estheticians as they begin their journey and advance their careers and businesses in the growing field of esthetics; a profession that is projected to grow 10 percent through 2033.1 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241015294542/en/Hydrafacial Treatment
Increases Skin Hydration by Over 300 Percent and Reduces the Appearance of Wrinkles by 63 Percent After One Treatment The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial®, today announced the global launch of the Hydrafacial Hydralock HA Booster, a proprietary formulation backed by clinical testing that delivers the signature Hydrafacial glow and keeps on giving. Clinically proven to increase hydration by three times, the formula helps plump and firm the skin, delivers 24-hour moisture and glow and reduces the appearance of wrinkles by 63 percent after just one treatment. 1 This press release features multimedia. View the full release here: https://www.businesswire.
Delivers second quarter net sales of $90.6 million; Year-over-year operating expense improvement of nearly $18 million or 22%; Revises full year financial guidance The Beauty Health Company (NASDAQ:SKIN) ("BeautyHealth"), home to flagship brand Hydrafacial, today announced financial results for the second quarter ended June 30, 2024 ("Q2 2024"). For the quarter, net sales of $90.6 million decreased (22.9)% relative to the same period in 2023. Second quarter results reflect lower equipment sales partially offset by steady growth in consumables net sales. "Our second quarter results reflect continued demand for Hydrafacial treatments with growth in consumables sales, offset by a slowe
The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial™, today announced it will report second quarter 2024 financial results after market close on Thursday, August 8, 2024. The Company will host an investor conference call at 4:30 p.m. Eastern Time, following a press release detailing the results. A live webcast of the call can be accessed on the Company's investor relations website at https://investors.beautyhealth.com, along with supporting materials. A recording of the call will become available on the site approximately three hours after its conclusion. Disclosure Information The Beauty Health Company announces material information to the public through a var
Delivers first quarter net sales of $81.4 million; year-over-year operating expense improvement of $6.1 million Repurchases $192.3 million of convertible notes through May 8th The Beauty Health Company (NASDAQ:SKIN) ("BeautyHealth"), home to flagship brand Hydrafacial, today announced financial results for the first quarter ended March 31, 2024. First quarter net sales of $81.4 million decreased (5.7)% relative to the same period in 2023. First quarter results reflect lower equipment sales substantially offset by steady growth in consumables net sales. "Our first quarter results demonstrate the progress we are making on our near-term strategic priorities, including sales excellence, o
The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial™, today announced it will report first quarter 2024 financial results after market close on Thursday, May 9, 2024. The Company will host an investor conference call at 4:30 p.m. Eastern Time, following a press release detailing the results. A live webcast of the call can be accessed on the Company's investor relations website at https://investors.beautyhealth.com, along with supporting materials. A recording of the call will become available on the site approximately three hours after its conclusion. Disclosure Information The Beauty Health Company announces material information to the public through a variety o
The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial, today announced the appointment of two accomplished industry executives to its commercial leadership team. Ron Menezes will join Beauty Health as Chief Revenue Officer and Carrie Caulkins will join the Company as Chief Marketing Officer, effective October 15, 2024, with both reporting to the Company's Chief Executive Officer, Marla Beck. Mr. Menezes assumes his new role from Dan ("Doc") Watson, who is leaving Beauty Health and will assist with the transition through year-end. Ms. Caulkins fills an open position. Marla Beck commented on the appointments, "We are thrilled to welcome Ron and Carrie to the executive t
The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial, today announced that it has appointed Sheri Lewis as Chief Supply Chain and Operations Officer, effective immediately. Ms. Lewis will report to BeautyHealth's President and Chief Executive Officer, Marla Beck. "Sheri is a talented and deeply experienced executive who brings decades of valuable global operations expertise to BeautyHealth as we chart the future of the Company," said Marla Beck, BeautyHealth President and Chief Executive Officer. "The Board of Directors and I are confident that her deep industry experience across global supply chain and operations will play a critical role in advancing our strategic
The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial, today announced its Board of Directors has unanimously approved Marla Beck as the Company's permanent President and Chief Executive Officer. Ms. Beck has been Interim CEO since November 20, 2023, in addition to serving on the Company's Board of Directors, which she will continue to do going forward. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240312423257/en/SKIN) (Photo: Business Wire)">Marla Beck, President and Chief Executive Officer, The Beauty Health Company (NASDAQ:SKIN) (Photo: Business Wire) "Over the past few months, the Board has undertaken
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Nov. 20, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises The Beauty Health Company ("Beauty Health" or the "Company") (NASDAQ:SKIN) investors that a lawsuit filed on behalf of investors that purchased Beauty Health securities between May 10, 2022 and November 13, 2023 , both dates inclusive (the "Class Period"). Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 844-767-8529 or email: [email protected], to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluatio
Beauty Industry Veteran and BeautyHealth Director Marla Beck to Serve as Interim CEO, Succeeding Andrew Stanleick The BeautyHealth Company (NASDAQ:SKIN), home to flagship brand Hydrafacial, today announced that Andrew Stanleick will depart the Company as President & Chief Executive Officer and relinquish his Board seat, effective November 19, 2023. Current BeautyHealth Director Marla Beck will serve as Interim Chief Executive Officer while the Company's Board of Directors completes a formal search for a new CEO. "On behalf of the Board of Directors, I would like to thank Andrew for his leadership and commitment to BeautyHealth. He has been a passionate advocate for the Company, especial
Newly created role establishes end-to-end product oversight, from innovation to go-to-market The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial, today announced Brad Hauser's promotion to Chief Operating Officer (COO), a new position within the company. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230419005942/en/Brad Hauser appointed Chief Operating Officer, BeautyHealth. (Photo: Business Wire Brad will assume end-to-end Operating leadership, overseeing the company's full product lifecycle, from ideation and innovation to go-to-market. He will continue to lead the Product organization, including tec
Joins Executive Committee to strengthen global infrastructure, help fuel company's next phase of profitable growth The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial, today announced the appointment of David Aquino as Executive Vice President, Global Operations, a new position within the company. David joins the Executive Committee and will lead global supply chain, quality, distribution and logistics. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221102005155/en/David Aquino, Executive Vice President, Global Operations, BeautyHealth (Photo: Business Wire) This appointment comes as BeautyHealth looks to
Beauty industry vet Jon Arnold returns to EMEA to lead growth acceleration Stefanie Gebauer brings skin and hair expertise to drive critical SEA development The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial, today strengthened its commercial leadership with the appointment of Jon Arnold as President, EMEA, and Stefanie Gebauer as President, Southeast Asia. The two leaders will join BeautyHealth's Executive Committee and drive end-to-end commercial operations in their respective regions, overseeing in-market teams, the local P&L, go-to-market strategy, marketing and sales. This press release features multimedia. View the full release here: https://www.businesswire
The Beauty Health Company (NASDAQ:SKIN), the breakthrough category creator at the intersection of traditional beauty and aesthetics with its flagship HydraFacial brand, today announced the appointment of Marla Beck to its Board of Directors. The Bluemercury founder will join the Board effective immediately. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220606005606/en/Marla Beck (Photo: Business Wire) A serial entrepreneur and visionary brand-builder, Ms. Beck has deep experience leading rapid growth-stage companies. As founder and former CEO of Bluemercury, the disruptive omnichannel beauty retailer founded in 1999 and acquired
The Beauty Health Company (NASDAQ:SKIN), the breakthrough category creator at the intersection of traditional beauty and aesthetics, today announced that Amy Juaristi has been appointed Head of Corporate Affairs, a newly created role. Ms. Juaristi will join BeautyHealth's Executive Committee and lead the development, advancement, and execution of the company's strategic communications and public affairs strategy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220508005079/en/Amy Juaristi, Head of Corporate Affairs, The Beauty Health Company (Photo: Business Wire) Ms. Juaristi has spent two decades in beauty, consumer goods, and h
SC 13G/A - Beauty Health Co (0001818093) (Subject)
SC 13G/A - Beauty Health Co (0001818093) (Subject)
SC 13G/A - Beauty Health Co (0001818093) (Subject)
SC 13G/A - Beauty Health Co (0001818093) (Subject)
SC 13G/A - Beauty Health Co (0001818093) (Subject)
SC 13G/A - Beauty Health Co (0001818093) (Subject)
SC 13G - Beauty Health Co (0001818093) (Subject)
SC 13G/A - Beauty Health Co (0001818093) (Subject)
SC 13D/A - Beauty Health Co (0001818093) (Subject)
SC 13G/A - Beauty Health Co (0001818093) (Subject)
10-Q - Beauty Health Co (0001818093) (Filer)
8-K - Beauty Health Co (0001818093) (Filer)
8-K/A - Beauty Health Co (0001818093) (Filer)
8-K - Beauty Health Co (0001818093) (Filer)
8-K - Beauty Health Co (0001818093) (Filer)
10-Q - Beauty Health Co (0001818093) (Filer)
8-K - Beauty Health Co (0001818093) (Filer)
8-K - Beauty Health Co (0001818093) (Filer)
10-Q - Beauty Health Co (0001818093) (Filer)
8-K - Beauty Health Co (0001818093) (Filer)
4 analysts have expressed a variety of opinions on Beauty Health (NASDAQ:SKIN) over the past quarter, offering a diverse set of opinions from bullish to bearish. The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 0 1 2 0 Last 30D 0 0 0 1 0 1M Ago 0 0 0 0 0 2M Ago 1 0 1 0 0 3M Ago 0 0 0 1 0 Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $3.0, with a high estimate of $5.00 and a low estimate of $1.50. A decline of 17.
Piper Sandler analyst Korinne Wolfmeyer maintains Beauty Health (NASDAQ:SKIN) with a Underweight and lowers the price target from $2.5 to $1.5.
Shares of Virios Therapeutics, Inc. (NASDAQ:VIRI) fell sharply during Monday's session after the company priced a $1.7 million public offering of 8.5 million shares of common stock at $0.20 per share. Virios Therapeutics shares dipped 47.6% to $0.1850 on Monday. Here are some other stocks moving in today’s mid-day session. Gainers MultiMetaVerse Holdings Limited (NASDAQ:MMV) shares jumped 224% to $2.01. MultiMetaVerse Holdings signed a non-binding term sheet to acquire 100% of Bowong Technology (Shenzhen) Co., Ltd. and its subsidiaries. GT Biopharma, Inc. (NASDAQ:GTBP) rose 146% to $7.64. GT Biopharma, last week, posted a narrower-than-expected quarterly loss. Tantech Hold
DA Davidson analyst Linda Bolton Weiser maintains Beauty Health (NASDAQ:SKIN) with a Buy and maintains $5 price target.
TD Cowen analyst Oliver Chen maintains Beauty Health (NASDAQ:SKIN) with a Hold and lowers the price target from $4 to $3.
Shares of Diodes Incorporated (NASDAQ:DIOD) fell sharply during Friday's session after the company reported worse-than-expected quarterly financial results. Diodes posted adjusted earnings of 28 cents per share, missing market estimates of 31 cents per share. The company's quarterly sales came in at $301.97 million missing expectations of $305.01 million, according to data from Benzinga Pro. Diodes shares dipped 9.8% to $68.99 on Friday. Here are some other stocks moving in today’s mid-day session. Gainers Novavax, Inc. (NASDAQ:NVAX) shares jumped 139% to $10.73 after the company and Sanofi announced a co-exclusive licensing agreement to commercialize a COVID-19 vaccine and d
Piper Sandler analyst Korinne Wolfmeyer maintains Beauty Health (NASDAQ:SKIN) with a Underweight and lowers the price target from $3 to $2.5.